New York biotech has historically lagged behind more established life sciences hubs like Boston and San Francisco, but collaborations between its research institutions have helped the city start to move forward. Another step in that direction was taken this morning, with the launch of what’s being called Bridge Medicines.
{iframe}http://www.xconomy.com/new-york/2016/10/31/new-york-institutions-vcs-team-up-to-build-drug-discovery-bridge/?utm_source=Xconomy&utm_campaign=9de90b8506-NEWSLETTER_all_stories&utm_medium=email&utm_term=0_2aa91c0bc9-9de90b8506-288460969#{/iframe}